齐墩果酸衍生物巴多索隆通过破坏细胞膜和丙酮酸代谢途径对抗耐多药金黄色葡萄球菌
该研究评估齐墩果酸衍生物巴多索隆对耐多药金黄色葡萄球菌的抗菌效果与机制。体外对浮游、内化及生物膜态耐多药菌均有强抗菌活性且耐药潜力低,小鼠肺炎与大腿脓肿模型中显著提高生存率、降低菌负荷并减轻炎症。机制涉及破坏膜完整性与抑制丙酮酸代谢。
要点
- 巴多索隆对金黄色葡萄球菌及其他革兰阳性病原体显示强效抗菌活性。
- 对內化及生物膜相关耐多药金黄色葡萄球菌有强抗菌活性,耐药潜力低。
- 小鼠感染模型中显著提高生存率、降低菌负荷并减轻肺与股部组织炎症反应。
核心结论
- 巴多索隆有望成为治疗难治性耐多药金黄色葡萄球菌感染的候选药物。
研究设计与样本
- 系统评估天然产物及其衍生物的抗菌活性,并在体外及小鼠肺炎和大腿脓肿感染模型中评估巴多索隆。
- 通过定量蛋白质组学和系列生化实验探究抗菌机制。
主要发现
- 巴多索隆对金黄色葡萄球菌及其他革兰阳性病原体表现出强效抗菌 efficacy。
- 对內化和生物膜相关耐多药金黄色葡萄球菌显示强抗菌活性,耐药潜力低。
- 小鼠感染模型中治疗显著提高生存率,降低细菌负荷并减轻肺和股部组织炎症反应。
- 机制分析揭示双重抗菌作用:破坏膜完整性和抑制丙酮酸代谢,表现为关键酶活性降低、乙酰辅酶A/ATP合成减少及生长抑制。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Staphylococcus aureus poses a significant threat to human health, making it imperative to develop novel antimicrobial agents to combat infections caused by this pathogen. OBJECTIVES: To evaluate the antibacterial efficacy and elucidate the mechanism of bardoxolone as a potential agent against multidrug-resistant S. aureus. METHODS: Natural products and their derivatives were systematically evaluated for antibacterial activity. The antibacterial activity of bardoxolone was assessed in vitro against planktonic bacteria, internalized bacteria and biofilm-forming multidrug-resistant S. aureus, as well as in vivo using mouse pneumonia and thigh abscess infection models. The underlying antibacterial mechanisms were investigated through quantitative proteomics and a series of biochemical assays. RESULTS: Bardoxolone exhibited potent antibacterial efficacy against S. aureus and other Gram-positive pathogens. It demonstrated strong antibacterial activity against internalized and biofilm-associated multidrug-resistant S. aureus, showing low resistance potential. In murine infection models, treatment significantly enhanced survival rates while reducing bacterial burden and attenuating inflammatory responses in pulmonary and femoral tissues. Mechanistic analyses revealed dual antibacterial actions: membrane integrity disruption and suppression of pyruvate metabolism, manifesting as diminished activity of pivotal enzymes, reduced acetyl-CoA/ATP synthesis and consequent growth inhibition of S. aureus. CONCLUSIONS: These findings suggest that bardoxolone holds promise as a candidate drug for treating refractory multidrug-resistant S. aureus infections.
引用
- Zheng YD, Xu J, Wu J, et al. Oleanolic acid derivative bardoxolone combats multidrug-resistant Staphylococcus aureus by destroying cell membrane and pyruvate metabolism pathway. J Antimicrob Chemother. 2025. PMID: 40492526. doi:10.1093/jac/dkaf190
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。